Rick Patt, MD, Co-Founder, and Principal of RadMD, led the first webinar of 2024, highlighting live blinded central reads (BICR) in cancer trials. Here are the key points that were covered:

  • Definition and operational mechanisms of “live reads.”
  • Importance and benefits of conducting live reads.
  • Consideration of potential drawbacks associated with live reads.
  • Practical strategies for operationalizing live reads.
  • Optimal scenarios for leveraging live reads in cancer trial settings.

For those who missed the live session, the webinar recording is now available for viewing here.